Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Aleniglipron

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Gasherbrum Bio, Inc · Phase 3 · Recruiting · Enrollment 1100

NCT07654374

ArmPopulationDoseWeeksEstimandWeight change
aleniglipron Arm 1Obesity + T2Dn/r76n/rn/r
aleniglipron Arm 2Obesity + T2Dn/r76n/rn/r
aleniglipron Arm 3Obesity + T2Dn/r76n/rn/r
Placebo Arm 4Obesity + T2Dn/r76n/rn/r